Clinical Trial Update: Phase 0 Biodistribution of Novel Imaging for Resectable Pancreatic Cancer [EARLY_Phase 1]

View source ↗

Summary

Clinical trial update on Phase 0 biodistribution of a novel imaging agent for resectable pancreatic ductal adenocarcinoma. The study status is TERMINATED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: University of Virginia | Conditions: Pancreatic Ductal Adenocarcinoma | EARLY_Phase 1 | Status: TERMINATED